IS6263A - Lyfjasamsetningar, sem innihalda trípeptíð - Google Patents
Lyfjasamsetningar, sem innihalda trípeptíðInfo
- Publication number
- IS6263A IS6263A IS6263A IS6263A IS6263A IS 6263 A IS6263 A IS 6263A IS 6263 A IS6263 A IS 6263A IS 6263 A IS6263 A IS 6263A IS 6263 A IS6263 A IS 6263A
- Authority
- IS
- Iceland
- Prior art keywords
- pharmaceutical formulations
- formulations containing
- containing tripeptide
- tripeptide
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14798199P | 1999-08-09 | 1999-08-09 | |
PCT/IB2000/000972 WO2001010457A2 (en) | 1999-08-09 | 2000-06-29 | Pharmaceutical compositions containing tripeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
IS6263A true IS6263A (is) | 2002-02-08 |
Family
ID=22523732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6263A IS6263A (is) | 1999-08-09 | 2002-02-08 | Lyfjasamsetningar, sem innihalda trípeptíð |
Country Status (16)
Country | Link |
---|---|
US (1) | US20030050242A1 (is) |
EP (1) | EP1207897A2 (is) |
JP (1) | JP2003506411A (is) |
KR (1) | KR20020019126A (is) |
CN (1) | CN1377276A (is) |
AU (1) | AU5701300A (is) |
CA (1) | CA2378480A1 (is) |
CZ (1) | CZ2002421A3 (is) |
HU (1) | HUP0202512A2 (is) |
IL (1) | IL147970A0 (is) |
IS (1) | IS6263A (is) |
MX (1) | MXPA02001349A (is) |
NO (1) | NO20020635L (is) |
PL (1) | PL354122A1 (is) |
RU (1) | RU2002102868A (is) |
WO (1) | WO2001010457A2 (is) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1138692A1 (en) | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US8680059B2 (en) | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
US6844315B2 (en) | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
US6593455B2 (en) | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
US6455670B1 (en) | 2001-09-06 | 2002-09-24 | Tripep Ab | Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof |
EP1436317A1 (en) | 2001-09-19 | 2004-07-14 | Tripep Ab | Molecules that block viral infectivity and methods of use thereof |
US7786084B2 (en) | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US20040052928A1 (en) | 2002-09-06 | 2004-03-18 | Ehud Gazit | Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
US7491699B2 (en) | 2002-12-09 | 2009-02-17 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
DE602004020179D1 (de) | 2003-01-07 | 2009-05-07 | Univ Ramot | Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben |
TWI344371B (en) * | 2003-03-18 | 2011-07-01 | Suntory Holdings Ltd | Angiotensin-converting enzyme inhibitory peptides |
DK1608281T3 (en) | 2003-04-03 | 2016-10-31 | Galil Medical Ltd | DEVICE FOR EXACTLY LIMITED CRYOABLATION |
EP1638517A4 (en) | 2003-06-30 | 2010-01-06 | Univ Tel Aviv Future Tech Dev | PEPTIDES, ANTIBODIES AGAINST DISEASES ASSOCIATED WITH AMYLOID AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF THESE DISEASES |
CA2540407A1 (en) | 2003-09-25 | 2005-03-31 | Tel Aviv University Future Technology Development L.P. | Compositions and methods using same for treating amyloid-associated diseases |
US20090156471A1 (en) * | 2004-07-15 | 2009-06-18 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
WO2006013552A2 (en) | 2004-08-02 | 2006-02-09 | Ramot At Tel Aviv University Ltd. | Articles of peptide nanostructures and method of forming the same |
ATE539745T1 (de) | 2004-08-19 | 2012-01-15 | Univ Tel Aviv Future Tech Dev | Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen |
SG163567A1 (en) | 2005-07-05 | 2010-08-30 | Biotempt Bv | Treatment of tumors |
EP1973928A2 (en) | 2005-10-11 | 2008-10-01 | Ramot at Tel-Aviv University Ltd. | Self-assembled fmoc-ff hydrogels |
DE102005050557A1 (de) * | 2005-10-17 | 2007-04-19 | Universität Tübingen | SRF als diagnostisches und/oder therapeutisches Target für Erkrankungen, die mit neuronalen Abnormalitäten assoziiert sind |
GB2433591A (en) * | 2005-12-20 | 2007-06-27 | Sharp Kk | Method for functionalising a hydrophobic substrate |
GB2433505A (en) * | 2005-12-20 | 2007-06-27 | Sharp Kk | Capture agents for binding a ligand |
GB2433506A (en) * | 2005-12-20 | 2007-06-27 | Sharp Kk | A method of producing a multimeric capture agent |
EP1864692A1 (en) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
US9463195B2 (en) * | 2006-12-15 | 2016-10-11 | The Regents Of The University Of California | Dissolution of amyloid fibrils by flavonoids and other compounds |
US20100240591A1 (en) * | 2007-06-25 | 2010-09-23 | Oncoreg Ab | Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
GB0716494D0 (en) * | 2007-08-23 | 2007-10-03 | Isis Innovation | HIV-2 antigenic peptides |
WO2010124262A1 (en) * | 2009-04-24 | 2010-10-28 | Allostera Pharma Inc. | Methods of identification of allosteramers and uses thereof |
EP2640737B1 (en) | 2010-11-15 | 2018-08-29 | Ramot at Tel-Aviv University Ltd. | Dipeptide analogs for treating conditions associated with amyloid fibril formation |
WO2012070971A1 (ru) * | 2010-11-22 | 2012-05-31 | Farber Boris Slavinovich | Косметологическая и фармацевтическая композиция для омоложения и восстанов- ления кожи, в том числе после хирургических операций |
WO2014184596A2 (en) * | 2013-05-17 | 2014-11-20 | Szegedi Tudomanyegyetem | SMALL PEPTIDE INHIBITORS OF β-AMYLOID TOXICITY |
EP2913338A1 (en) | 2014-02-28 | 2015-09-02 | Roche Diagniostics GmbH | Soluable and immunoreactive variants of HTLV capsid antigen p24 |
KR101693682B1 (ko) * | 2014-03-21 | 2017-01-09 | 서울대학교병원 (분사무소) | Acq를 포함하는 항산화용 화장품 조성물 |
CN104258371B (zh) * | 2014-09-25 | 2016-06-15 | 中山大学 | Www三肽在制备治疗阿尔茨海默症药物中的用途 |
CN104324359B (zh) * | 2014-09-25 | 2016-08-17 | 中山大学 | Rry三肽在制备治疗阿尔茨海默症药物中的用途 |
CN104306954B (zh) * | 2014-09-25 | 2016-08-24 | 中山大学 | Wry三肽在制备治疗阿尔茨海默症药物中的用途 |
JP6613312B2 (ja) * | 2014-10-14 | 2019-11-27 | ジ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンティッド バイ ザ セクレタリー,デパートメント オブ ヘルス アンド ヒューマン サービシズ | 膵臓癌を処置するためのペプチドをベースとする方法 |
GB201613999D0 (en) | 2016-08-16 | 2016-09-28 | Neuro-Bio Ltd | Neurodegenerative disorders |
WO2023214802A1 (ko) * | 2022-05-03 | 2023-11-09 | 한국생명공학연구원 | 신규 펩타이드 및 이의 항염 및 재생 용도 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1063727A (en) * | 1912-07-31 | 1913-06-03 | William J Pierce | Bed-caster. |
US4215112A (en) * | 1979-03-14 | 1980-07-29 | Ortho Pharmaceutical Corporation | Tripeptides and methods |
US4658013A (en) * | 1981-07-28 | 1987-04-14 | Sterling Drug Inc. | Analgesic and/or opiate antagonist tripeptide amides and processes for preparation and compositions thereof |
CS231228B1 (en) * | 1982-10-01 | 1984-10-15 | Evzen Kasafirek | Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method |
US4857538A (en) * | 1987-11-30 | 1989-08-15 | The Research Foundation Of State University Of New York | New compounds for the study and treatment of microfilament organization in cells |
US4950647A (en) * | 1988-10-04 | 1990-08-21 | Nucleic Acid Research Institute | T cell immunopotentiator |
IT1231342B (it) * | 1989-08-28 | 1991-11-28 | Prodotti Antibiotici Spa | Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono |
US5336758A (en) * | 1990-03-09 | 1994-08-09 | The United States Of America As Represented By The Department Of Health And Human Services | Peptides stimulating cytotoxic T cells immune to HIV RT |
DE4014655A1 (de) * | 1990-05-08 | 1991-11-14 | Behringwerke Ag | Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren |
US5627035A (en) * | 1990-08-22 | 1997-05-06 | Syntello Vaccine Development Ab | Peptides that block human immunodeficiency virus and methods of use thereof |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
EP0502198B1 (en) * | 1990-09-11 | 1995-12-27 | Seikagaku Kogyo Co., Ltd. | Novel polypeptide and anti-hiv drug prepared therefrom |
GB9024129D0 (en) * | 1990-11-06 | 1990-12-19 | Thrombosis Research Trust | Inhibitors and substrates of thrombin |
HUT61036A (en) * | 1991-05-02 | 1992-11-30 | Seikagaku Kogyo Co Ltd | Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients |
JP3266311B2 (ja) * | 1991-05-02 | 2002-03-18 | 生化学工業株式会社 | 新規ポリペプチドおよびこれを用いる抗hiv剤 |
EP0584238A1 (en) * | 1991-05-17 | 1994-03-02 | Chiron Corporation | INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
US5856122A (en) * | 1993-08-24 | 1999-01-05 | University Of Alberta | Modification of pertussis toxin |
FR2710340B1 (fr) * | 1993-09-22 | 1995-12-15 | D Hinterland Lucien Dussourd | Dérivés peptidiques de l'alpha-MSH et leur application . |
US5470951A (en) * | 1993-09-29 | 1995-11-28 | City Of Hope | Peptides for antagonizing the effects of amyloid βprotein |
HU217442B (hu) * | 1993-10-14 | 2000-01-28 | Seikagaku Corp. | Polipeptidek és ezeket tartalmazó HIV-ellenes hatású gyógyászati készítmények |
US5744368A (en) * | 1993-11-04 | 1998-04-28 | Research Foundation Of State University Of New York | Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR) |
US5726156A (en) * | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
EP0815134B1 (en) * | 1995-03-14 | 2002-06-05 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
US5817626A (en) * | 1995-03-14 | 1998-10-06 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation |
AU701279B2 (en) * | 1995-05-10 | 1999-01-21 | Darwin Discovery Limited | Peptide compounds which inhibit metalloproteinase and TNF liberation and their therapeutic uses |
US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5770620A (en) * | 1995-06-19 | 1998-06-23 | Ontogen Corporation | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
CA2179935C (en) * | 1995-06-30 | 2010-09-07 | Ryohei Kato | Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
US5872210A (en) * | 1995-10-05 | 1999-02-16 | The United States Of America As Represented By The Department Of Health And Human Services | Transframe peptide inhibitor of viral protease |
US5830910A (en) * | 1995-10-23 | 1998-11-03 | University Of Kentucky Research Foundation | Cytochalasins useful in providing protection against nerve cell injury associated with neurodegenerative disorders |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
WO1997037228A1 (en) * | 1996-03-29 | 1997-10-09 | The Trustees Of Boston University | Methods for diagnosing and treating alzheimer's disease |
US6126939A (en) * | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
US5886025A (en) * | 1997-03-06 | 1999-03-23 | Baylor University | Anti-mitotic agents which inhibit tubulin polymerization |
US5843995A (en) * | 1997-07-07 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Inhibition of HIV-1 replication using oligocarbamate derivatives |
US5952483A (en) * | 1997-07-31 | 1999-09-14 | Smithkline Beecham Corporation | Human IκB-β |
WO1999009056A1 (en) * | 1997-08-19 | 1999-02-25 | University Of Medicine And Dentistry Of New Jersey | Inhibition of hiv-1 replication using d-amino acid peptides |
US6184210B1 (en) * | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
US6258932B1 (en) * | 1999-08-09 | 2001-07-10 | Tripep Ab | Peptides that block viral infectivity and methods of use thereof |
US6455670B1 (en) * | 2001-09-06 | 2002-09-24 | Tripep Ab | Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof |
-
2000
- 2000-06-29 CA CA002378480A patent/CA2378480A1/en not_active Abandoned
- 2000-06-29 MX MXPA02001349A patent/MXPA02001349A/es unknown
- 2000-06-29 HU HU0202512A patent/HUP0202512A2/hu unknown
- 2000-06-29 WO PCT/IB2000/000972 patent/WO2001010457A2/en not_active Application Discontinuation
- 2000-06-29 IL IL14797000A patent/IL147970A0/xx unknown
- 2000-06-29 KR KR1020027001868A patent/KR20020019126A/ko not_active Application Discontinuation
- 2000-06-29 AU AU57013/00A patent/AU5701300A/en not_active Abandoned
- 2000-06-29 JP JP2001514973A patent/JP2003506411A/ja active Pending
- 2000-06-29 CN CN00813617A patent/CN1377276A/zh active Pending
- 2000-06-29 PL PL00354122A patent/PL354122A1/xx unknown
- 2000-06-29 CZ CZ2002421A patent/CZ2002421A3/cs unknown
- 2000-06-29 EP EP00942321A patent/EP1207897A2/en not_active Withdrawn
- 2000-06-29 RU RU2002102868/15A patent/RU2002102868A/ru unknown
-
2002
- 2002-02-08 NO NO20020635A patent/NO20020635L/no not_active Application Discontinuation
- 2002-02-08 US US10/072,783 patent/US20030050242A1/en not_active Abandoned
- 2002-02-08 IS IS6263A patent/IS6263A/is unknown
Also Published As
Publication number | Publication date |
---|---|
IL147970A0 (en) | 2002-09-12 |
JP2003506411A (ja) | 2003-02-18 |
EP1207897A2 (en) | 2002-05-29 |
CA2378480A1 (en) | 2001-02-15 |
PL354122A1 (en) | 2003-12-29 |
WO2001010457A2 (en) | 2001-02-15 |
MXPA02001349A (es) | 2002-07-22 |
KR20020019126A (ko) | 2002-03-09 |
HUP0202512A2 (hu) | 2002-11-28 |
CZ2002421A3 (cs) | 2002-09-11 |
AU5701300A (en) | 2001-03-05 |
NO20020635L (no) | 2002-03-15 |
NO20020635D0 (no) | 2002-02-08 |
RU2002102868A (ru) | 2004-01-27 |
WO2001010457A3 (en) | 2001-08-30 |
CN1377276A (zh) | 2002-10-30 |
US20030050242A1 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6263A (is) | Lyfjasamsetningar, sem innihalda trípeptíð | |
IS2004B (is) | Lyfjasamsetningar sem innihalda vorikónasól | |
TR199901077A3 (tr) | Ispençiyari formülasyonlar. | |
NO20015175D0 (no) | Farmasöytisk sammensetning | |
HUP0202513A3 (en) | Betha-carboline pharmaceutical compositions | |
PT1242087E (pt) | Composicoes farmaceuticas | |
ZA200200743B (en) | Preserved pharmaceutical formulations. | |
GB0001662D0 (en) | Pharmaceutical compositions | |
NO20015670D0 (no) | Forbedrede farmasöytiske formuleringer | |
GB9923436D0 (en) | Pharmaceutical compositions | |
ZA200000857B (en) | Pharmaceutical composition. | |
PT1239832E (pt) | Composicoes farmaceuticas | |
GB9904163D0 (en) | Pharmaceutical compositions | |
DE10084344T1 (de) | Cyclosporin enthaltende pharmazeutische Zusammensetzung | |
IS6021A (is) | Lyfjasamsetningar sem innihalda sítalópram | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
GB9911017D0 (en) | Pharmaceutical compositions | |
EP1173216A4 (en) | PHARMACEUTICAL FORMULATIONS | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
HUP0201696A2 (en) | Cyclic peptides, pharmaceutical compositions comprising thereof and their use | |
IL147731A0 (en) | Peptide pharmaceutical formulations | |
GB9904911D0 (en) | Pharmaceutical compositions | |
GB9930578D0 (en) | Pharmaceutical formulations | |
GB9906126D0 (en) | Pharmaceutical formulations | |
GB9902651D0 (en) | Pharmaceutical compositions |